title: [Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].
abstract: We analyze the survival rate in 17 pediatric patients (twelve males and five females) that were diagnoses of non-Hodgkin's lymphoblastic lymphoma (cases with Burkitt's lymphoma were excluded) during the period from 1982 to 1990. All of them were treated using the LSA2-L2 therapeutic protocol. The follow-up period ranged from 14 to 99 months (follow-up median 43 months). Staging of our newly diagnosed patients, we found 9 patients in stage III and 8 in stage IV disease. Survival was analyzed by the Kaplan-Meier method. The overall survival rate of our patients is 69.5% and the disease free survival is 62.6%. The disease free survival for separated stages is 66.5% for stage III and 58.3% for stage IV. We compare our results with other casuisties published in literature.
authors.affiliation: Unidad de Oncopediatría, Hospital Infantil Miguel Servet, Zaragoza.
authors.forename: J
authors.initials: J
authors.lastname: Pisón Garcés
authors.forename: J C
authors.initials: JC
authors.lastname: Buñuel Alvarez
authors.forename: M P
authors.initials: MP
authors.lastname: Domínguez Fenollé
authors.forename: J A
authors.initials: JA
authors.lastname: Castillo Laita
authors.forename: T
authors.initials: T
authors.lastname: Cenarro Guerrero
authors.forename: M J
authors.initials: MJ
authors.lastname: Monreal Gálvez
authors.forename: T
authors.initials: T
authors.lastname: Arana Navarro
authors.forename: A
authors.initials: A
authors.lastname: Hernández Gayá
mesh_terms: D002648:Child; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D013030:Spain / Q000453:epidemiology; D015996:Survival Rate
vernacular_title: Linfoma no Hodgkin de tipo linfoblástico: evaluación de la supervivencia en pacientes con enfermedad diseminada (estadío III y IV) tratados con el protocolo LSA2-L2.